Ceradyne, Inc. has agreed to sell 1,800,000 shares of its common stock at a price of $43.31 per share in an underwritten public offering. The company has granted the underwriters a 30-day option to purchase up to an additional 270,000 shares of common stock to cover over-allotments. All of the shares are being offered by the company. Ceradyne has also announced that, concurrently with its agreement to sell shares of common stock, it has agreed to sell $110 million aggregate principal amount of 2.875% senior subordinated convertible notes due 2035 in an underwritten public offering. This represents an increase of $10 million in the aggregate principal amount of notes being offered from the amount announced on December 1, 2005. The company has granted the underwriters a 13-day option to purchase up to an additional $11 million of notes to cover over-allotments.
Additional details are available at www.ceradyne.com.